Latest Breaking News On - திறிச் பார்மா - Page 3 : comparemela.com

Intellipharmaceutics International Inc.: Intellipharmaceutics Announces First Quarter 2021 Results TORONTO, ON / ACCESSWIRE / April 14, 2021 / Intellipharmaceutics International Inc. (OTCQB:IPCIF)(TSX:IPCI) ( Intellipharmaceutics or the Company ), a pharmaceutical company specializing in the research, development and manufacture of novel and generic controlled-release and targeted-release oral solid dosage drugs, today reported the results of operations for the three months ended February 28, 2021. All dollar amounts referenced herein are in United States dollars unless otherwise noted. On July 2, 2020, the Company had announced that the parties in the cases, numbers 17-cv-392-RGA, 18-cv-404-RGA and 20-cv-515-RGA (the Litigations ) between Purdue Pharma L.P. et al ( Purdue ) and Intellipharmaceutics entered into a stipulated dismissal of the Litigations. The stipulated dismissal, which was subject to approval by the bankruptcy court presiding over Purdue Pharma s pending chapter

United statesPurdue pharmaIsa odidiCompany oxycodoneCompany contactUnited states district courtRisk management advisory committeeDrug products advisory committeeTris pharma incIntellipharmaceutics international incCompany aximrisHealth canadaIntellipharmaceutics internationalAnalgesic drug products advisory committeeDrug safetyAdvisory committee